Ultrathin (30 nm) carbon-doped titania nanofiltration membrane with precisely tunable molecular weight cut-off between 200 and 1,200 Da, delivering up to two orders of magnitude higher flux than commercial nanofiltration membranes for selective separation applications.
This technology is an ultrathin carbon-doped titania nanofiltration membrane with precisely controlled, molecular-sized pores. Formed via a fast interfacial reaction between organic precursors (such as ethylene glycol) and metal precursors (such as TiCl4), the resulting hybrid nanofilm is initially impermeable but can be converted into a porous nanofiltration membrane through controlled calcination. By adjusting the calcination gas environment (air or nitrogen) or the water content in the precursor mixture, the molecular weight cut-off (MWCO) of the membrane can be precisely tuned between 200 and 1,200 Daltons. This level of pore-size precision enables highly selective separation of target molecules while maintaining exceptional flux—approximately two orders of magnitude higher than commercial nanofiltration membranes—due to the membrane's ultrathin (~30 nm) architecture.
Potential applications include selective extraction of flavor and aroma compounds from food and beverage products, pharmaceutical purification, and other molecular-level separation processes requiring both high selectivity and high throughput.
The membrane fabrication process has been validated in laboratory settings, with demonstrated control over pore size and confirmed performance advantages over commercial alternatives. Current work includes forward osmosis testing using electrolyte draw solutions to selectively extract aldehydes, lactones, benzothiazoles, and alcohols from coconut water, with ongoing evaluation of optimal pore sizes for both selectivity and flux. Future validation will include long-term operational testing to assess commercial viability. The technology is at an early-to-mid stage of development, with proof-of-concept demonstrated and application-specific optimization underway.
University at Buffalo is a comprehensive public research university and a leading campus in the State University of New York system. Industry engagement is anchored by co-located labs on a downtown medical campus, a research and technology park with incubators, shared core facilities, and co-op talent pipelines. Partnerships with regional hospitals enable clinical studies and translation, while proximity to the U.S.–Canada border and the binational Great Lakes corridor facilitates cross‑border collaboration. Research is supported by competitive federal funding from NIH, NSF, DOE, and DoD, alongside New York State innovation programs. A dedicated technology transfer office provides IP management, licensing, and startup support.